And subsequently what we've disclosed is that we've dosed more patients in our EHA abstract, there is a greater number of patients, we have 14 patients; 10 thalassemia, 4 sickle cell patients. And maybe compare and contrast that with CD19, which is a little different? - Experienced in . The shares were sold at an average price of $48.25, for a transaction totalling $1,206,250.00. Now, ultimately when it comes to commercial and reimbursement, I think that'll be different by region, right. - Experienced in JAVA EE and core JAVA. And he will assume the role effective December 1, 2017. Research on various legal propositions regarding Indirect Tax Law. Samarth Kulkarni Net Worth The estimated Net Worth of Samarth Kulkarni is at least CRISPR Therapeutics AG stock worth over . In 2008, Leonard Lauder, chairman of Estee Lauder, was gifted Forest Essentials products by Lady Lynn Rothschild when he visited India to attend Elizabeth Hurleys wedding. Learn More about Samarth Kulkarni's net worth. 3 BHK Apartment for rent in Vikas Nagar, Pune - 1090 Sqft | Property ID Tech. Samarth Kulkarni Salary Infomation 2020 | ERI Economic Research Institute So did you -- interesting to think about as a -- as the leader in your particular modality, maybe thinking about your program, as well as potential competitor programs that might get advanced in the clinical trials in the future? CRISPR Therapeutics AG (CRSP) CEO Samarth Kulkarni on William Blair At Centessa Pharmaceuticals, Samarth Kulkarni has 25 colleagues including Saurabh Saha (CEO & Director), Francesco De Rubertis (Chairman of the Board) At Repare Therapeutics, Samarth Kulkarni has 14 colleagues including Lloyd Segal (CEO & Director), Jerel Davis (Director) Industry Colleagues Yes, absolutely. You know, this is a question on the oncology platform and the company commercialization strategy as a whole. Dr. Kulkarni, who serves as the CEO of the institution, studied in Rashtriya Military School and GSS Pre University College here. Sam, thank you for the time. Enter your email address below to get our daily insider buying and selling report. Kulkarni has four grandchildren, Shabad Shabad, Angad, Rhea, and Samaira. Chart Data in Insider Trading History Table. In the last year, insiders at the sold shares 9 times. Mira Kulkarni wrote a letter to the thirteen-year-old self which was published in Vogue Magazine in 2017. CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. A. Ghalge and P. Bhattacharyya, Information Extraction from Indo Aryan Family of Natural Languages Using a Rule . , Dr. Samarth (Sam) Kulkarni is the chief executive officer of CRISPR Therapeutics, a leading gene-editing company focused on the development of transformative medicines using its proprietary CRISPR/Cas9 platform. He took 5 wickets against Goa, 4 against Andhra Pradesh, 3 against Pondicherry and 5 against Kerala. Yes, I think data from different allogeneic players is good, it just basically signals that allogeneic therapies are here to stay. In 2003, Mira set up her first store in Khan Market, Delhi. Your email address will not be published. And I do think, the sheen is [ph] worn off some of the bispecifics; if you think about ASH last year or where we were last year, at this point, there was a lot of excitement by bispecifics. Rooms are spacious and four persons . This chart shows Samarth Kulkarni's buying and selling at CRISPR Therapeutics by year and by quarter. Sam also serves as the Chairman of the Board of Directors of Casebia Therapeutics, a joint subsidiary formed by CRISPR and Bayer. They cannot be abusive or personal. Sam currently serves on the Board of Directors of two precision oncology companies, Black Diamond Therapeutics and Repare Therapeutics. Lakshmikumaran and Sridharan. Dr. Kulkarni owns 375,988 shares of CRISPR Therapeutics stock worth more than $19,115,230 as of March 4th. Forest Essentials is also the leading supplier to the majority of the Luxury hotel chains in India including the iconic Taj Group of Hotels and The Oberoi Hotels. And the big switch, I think people are starting to understand allogeneic therapy is different from autologous therapy. . Log in or sign up for Facebook to connect with friends, family and people you know. And so we're learning more about CAR-Ts in general, and we're also learning more about allogeneic versus autologous therapies, and the same sort of metrics and lenses that you apply to autologous may not apply to allogeneic. Samarth Kulkarni's email & phone | Crispr Therapeutics's Chief Yes. Right. This 1090 Sqft 3 BHK 3toilet Apartment at 14.0k with all amenities only on Housing.com. CEO of Crispr Therapeutics Ag (30-Year Financial, Insider Trades) Samarth Kulkarni (insider trades) sold 20,000 shares of CRSP on 12/10/2020 at an average price of $142.29 a share. Samarth Kulkarni - Chief Executive Officer - LinkedIn PubHTML5 site will be inoperative during the times indicated! But in this context, as you look at the data, the trials are global; we're looking at the market in a way that there is a lot of shared responsibilities from a central global marketing, I would say, versus regional. from the Indian Institute of Technology. The estimated net worth of Samarth Kulkarni is at least $19 Million dollars as of 2023-02-16. Shillong (Meghalaya) - Violence erupted in three Constituencies after the results of the Assembly Elections in Meghalaya were declared. Samarths dedication to both his studies and cricket has made him a role model for many young cricketers, said his proud father Vinay Kulkarni. Developing new software and simulation models of the test stands for virtual commissioning. He has also worked for pharmaceutical and medical technology companies. He serves on the board of some technology companies. Dr. Hemant Kulkarni in the city Pune by the address Samarth Speciality Clinic, Next to Park Street, Wisdom World School, , Aundh-Ravet, Wakad, Pune, Maharashtra 411027, India . Ft. - Rent 2 BHK Apartment / Flat in Dhanori, Pune * 12 Property & locality photos * Unfurnished * - 2nd floor (out of 5). Nov. 2022-Heute3 Monate. Tech. She had appropriate expe more.. Share your story. Sam Kulkarni, Crispr Therapeutics Inc: Profile and Biography Sam the Indian connection to Nobel in Chemistry - The Hindu Facebook. If we need to, we'll go that route of the GSIs but at this point, we're trying to work with the original hypothesis which is that beta-2-M gives us that persistence; it won't be overwhelmed by the soluble BCMA, and -- but we still see responses. Your email address will not be published. All contact info about Samarth Kulkarni, 44 from Boston, Massachusetts - address, e-mail, phone, public records, etc at PublicReports FOR FREE Kulkarni will assume the role effective December 1, 2017. New Delhi - Supreme court, while hearing the appeal against a verdict of Tripura High Court, directed that world's best 'Z+' security be given to Mukesh Ambani and his family across the world and not only within Maharashtra or India. Please disable your ad-blocker and refresh. I have a technically sound background implied by educational achievements of mine aids me to be one of the best CFD engineer. You know, maybe just provide a little bit of color on how you're viewing CTX001 in the context of the clinical development landscape, obviously, a bunch of different modalities looking at HbH 87Q [ph], HbF and HbG [ph], for example. The New York Times Reports: "No existing defense can stop it." I am known for my . CRISPR Therapeutics can also be reached via phone at (141) 561-3277 and via email at [emailprotected] Learn More on Samarth Kulkarni's contact information. The Hindu Centre for Politics and Public Policy, Supreme Court forms expert panel to probe any regulatory failure on Adani issue, China says border should be kept in proper place, calls for resuming direct flights with India, India makes renewed push for consensus at G20 Foreign Ministers meeting, Seeping saffron: On the BJP and their partners electoral gains in the northeast, Searing changes: On heatwaves predicted by the Met Office, Sun Pharma reports information security incident, Embassy Group sells 4% stake in Embassy REIT to Bain Capital, 1947: Madras Devadasis (Prevention of Dedication) Act passed, World Test Championship points table update: India drops PCT, Australia qualifies for WTC final with Indore win; qualification scenarios. Samarth Kulkarni "Sam" Chief Executive Officer . This has come true in the matter of Vijayapura. I think generally our philosophy has been the first, the initial disclosure on programs has been as a company press release or a company release or presentation. With oncology, how we play in the long run is isn't -- it's a question that we evaluate every so often. So very full pipeline; we're very excited with everything that's going on, we're over 450 people now as a company, and expect to keep marching on, especially as our own manufacturing facility comes online next year. CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Our lead assets, CTX001 and hemoglobinopathies have shown remarkable data and could be potentially curative for patients suffering from sickle cell disease and beta thalassemia; we'll talk more about this program. Thanks for that. Samarth Bedi began his career with Standard Chartered Bank in New York in 1999, and in 2001, he joined Forest Essentials as the managing director. Some good, some not so much. You are at risk for having your bank account frozen. Learn More on Samarth Kulkarni's contact information. Beyond beauty, it is your inner self. How are you thinking about it now? Samarth Kulkarni - Training and Placement Student Coordinator - Sandip E/22, Jai mahalaxmi Society, Opp. In 2002, Hyatt Regency was its first customer by ordering soaps for their rooms. Samarth (Sam) Kulkarni, PhD, PhD - Global Health Care Initiative . CRISPR Therapeutics (NASDAQ:NASDAQ:CRSP) 4th Annual Evercore ISI HealthCONx Conference December 1, 2021 12:35 PM ETCompany ParticipantsSamarth Kulkarni - Chief Executive OfficerConference. CRISPR Therapeutics is not responsible for the content or availability of third-party sites. @CrisprSam. The most recent insider tranaction occured on February, 27th when CEO Samarth Kulkarni sold 25,000 shares worth more than $1,206,250.00. And I think, you know, the allogeneic therapies can always improve it overtime. But, you know, in all eventuality, you're going to get allo-therapies approved in the late-line settings. He has served as the companys Chief Business Officer and president before being promoted as CEO. Dr. Satish G Kulkarni (Samarth Diagnostic) in Vashi, Navi Mumbai, Mumbai is a top player in the category Gastroenterologists in the Navi Mumbai, Mumbai. Samarth Kulkarni's largest purchase order was 25,000 units, worth over $478K on December 30, 2022. CEO of Crispr Therapeutics Ag (30-Year Financial, Insider Trades) Samarth Kulkarni (insider trades) sold 20,000 shares of CRSP on 12/10/2020 at an average price of $142.29 a share. So maybe can you just talk about how the Vertex collaboration started? THE 10 BEST Restaurants Near Anand Resort in Nashik, Nashik District Beyond that, we have a very rich pipeline. Starting with our diabetes program, where we take artificial -- we've created artificial pancreas from iPS cells using CRISPR, and that -- that's going to the clinic by end of this year, and a number of in-vivo programs that are also moving towards the clinic rapidly. So I think while it's -- you know, won't be difficult for people to enroll patients because there is a lot of demand for gene editing in sickle cell and thalassemia, I think commercially, we are well positioned to take on that leadership mantle and maintain it overtime. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. 14 Years Experience Overall (12 years as specialist) Medical Registration Verified. I think this is like the medical device space, and shares are sticky because there are certain centers learned and trained themselves on a certain product, and it's not very easy to switch. In about six years we've gone from starting with a platform -- research platform to having multiple candidates in the clinic. You could hear the whispers eeks, whats that! from your friends. No. And what we're doing is creating an artificial -- a small device that serves the artificial pancreas and inserting it into the body. Expanded Access to Investigational Medicines. Project Highlights. I think there are a number of players that are following in our footsteps. Doctors for Colporrhaphy in Nashik-Pune Road, Nashik - Book Doctor Appointment, Consult Online, View Doctor Fees, User Reviews, Address and Phone Numbers of Doctors for Colporrhaphy | Lybrate Crispr Therapeutics Ag (CRSP) CEO Samarth Kulkarni Sold $3.8 - Yahoo! Careers at CRISPR, 2023 CRISPR Therapeutics. PubHTML5 Scheduled Server Maintenance on (GMT) Sunday, June 26th, 2:00 am - 8:00 am. Bispecifics have the same toxicity issues that autologous therapies have; and I do think allogeneic therapies are well poised now to becoming a very important part of the treatment landscape in lymphoma and other diseases. He received a doctorate from the University of Washington and an undergraduate degree from Indian Institute of Technology New Delhi. Dr. Samarth Kulkarni has served as Chief Executive Officer of CRISPR Therapuetics since December 2017. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. I think that our general goal is to take it all the way and commercialize ourselves. And as far as, you know, how -- the medium to expect the data from those programs; you've had some where you've done, obviously, in concert with a medical meeting, some you've done with a webcast event, press release. Yes, happy to do that. An industry leader with expertise in strategy and operations in biotech and a wide range of pioneering therapeutic technologies, Samarth (Sam) Kulkarni, Ph.D. currently serves as CEO of CRISPR Therapeutics AG. That will sometimes be difficult but that is what will set you apart from the rest. No credit card required. - Experienced in developing web applications using Spring and Hibernate framework. Management Team. Updated Jan 27, 2021. Copyright 2023, THG PUBLISHING PVT LTD. or its affiliated companies. And then, with the most recent deal with the negotiations over the 10%, and the control of the launch, how you were thinking about it from CRISPR's perspective? Mira Kulkarni owns a Glasshouse named Neemranas Glasshouse, a riverside property with 20 accommodations, which is located on the banks of the Ganges. document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() ); Mira Kulkarni Wiki, Age, Husband, Children, Family, Biography & More, Ashok Elluswamy Wiki, Age, Girlfriend, Wife, Family, Biography & More, Asish Mohapatra Wiki, Age, Wife, Family, Biography & More, Nithin Kamath Wiki, Age, Girlfriend, Wife, Children, Family, Biography & More, Mahhaguru Dr. Gauravv Mittal Wiki, Age, Family, Biography & More, Fahim Saleh Wiki, Age, Death, Girlfriend, Wife, Family, Biography & More, Anmol Ambani Wiki, Height, Age, Wife, Family, Biography & More, Anita Dongre Wiki, Age, Boyfriend, Husband, Family, Biography & More, Romil Ramgarhia Wiki, Age, Family, Biography & More, N. R. Narayana Murthy Wiki, Age, Wife, Children, Family, Biography & More, Sunny Kapoor Wiki, Age, Wife, Family, Biography & More, Lee Watson (Shane Watsons Wife) Wiki, Age,, Akshata Murthy Wiki, Age, Boyfriend, Husband, Family,, Kumar Mangalam Birla Wiki, Age, Wife, Children,, Akshat Shrivastava Wiki, Age, Wife, Family, Biography, J.R.D. If you're going to look to build out kind of commercial infrastructure to support global launches for that or do you partner one or more of those programs? Posts about Samarth Kulkarni written by Kevin McCormack. Email incorrect We have sent you an email with link. All rights reserved. Click here to check it out. He has conducted research on the delivery of biological drugs and molecular diagnostics. And that's a remarkable difference for these patients that were been living with serious disease their entire lives. We have the RMAT designation in the U.S. which gives us the ability to have frequent dialogue with regulators in the U.S. and PRIME designation in Europe which also gives the same ability to speak with the EMEA folks quite regularly. Great. So this one will be interesting to see the durability and the persistence of the cells and get an answer to those questions. Tech. I think it's an area that, you know, people have been trying to get responses for a long time. Dr. Samarth Kulkarni has served as our Chief Executive Officer since 2017. Signup today and get up to a 100% deposit bonus. Commissioning new test stands. This information is derived from proxy statements filed for the 2020 fiscal year.. In the case of thalassemia, those patients didn't require transfusion anymore within a couple of months of being treated with CTX001. He joined CRISPR in 2015 in the early stages of the company as Chief Business Officer, and then was appointed to President and Chief Business Officer before becoming CEO. Dr. Kulkarni owns 369,111 shares of CRISPR Therapeutics stock worth more than $17,724,710 as of February 25th. Yes. Shop No. He then moved to Bengaluru with his father, who is a Government servant, to pursue his cricketing career. Because I think -- why is that? You know, obviously with EHA coming up next week and the data update in sickle cell and beta thal; maybe provide just a little bit of context on what to expect in terms of data updates, obviously, you've provided updates in enrollment recently in trial. Click for complete details on 99acres.com CRISPR Therapeutics AG has a market cap of $10.49 billion; its shares were traded at around $148.410000 with and P/S ratio of 129.60. Post-poll violence that erupted in at least three assembly constituencies in Meghalaya left several people injured. With our oncology programs, we have three different CAR-Ts. We presented data there for 10 patients; 7 thalassemia and 3 sickle cell patients, and all 10 patients were symptom-free. But that's always things that we keep in our back pocket, I think, you know, we have very healthy cash balance but we don't want to be over reliant on equity financing. He has authored several publications in leading scientific and business journals. And then maybe after the ASH data, if you could provide any color on how physicians are looking at the data set to date? Prior to CRISPR, Sam was a partner at McKinsey & Company, where he had a leading role in the Pharmaceutical and Medical products practice. After returning to India, Kulkarni got involved in a cooperative movement in Rishikesh (Uttarakhand) that focused on marketing handmade products. The thing that you also didnt know then was that it takes courage to follow your dreams, and still have stars in your eyes. Samarth T Kulkarni. 2nd edition of MACE, an annual CME, held at FMMC, Bengaluru: Leopard issue, 410 attack cases in 1 District, Melbourne: Another Hindu temple bears brunt of Khalistani hatred in Australia, Hyderabad: Work on key steel bridge to be completed in 3 months, Bidar: MLA S Salgar presents 5 kg silver crown, mace to Shah, Chikkamagaluru: Group of friends show humanity by returning cash, The Courage to Be Disliked: How to find true joy in life, Walk for your health, make it your morning routine. You know, you're seeing response rates and CR rates that are similar to autologous therapies, right. Is that something that you think is a differentiator with 120 versus 110? But I think the beta-2-M strategy gives us that persistence, that's -- that's important for killing the cancer cells. Dr. Samarth Kulkarni has significant expertise in strategy and operations in biotech and a wide range of related cutting-edge therapeutic technologies. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. The price of the stock has decreased by 3.96% since. In the last ninety days, Samarth Kulkarni has sold $2,493,000.00 in shares of CRISPR Therapeutics stock. Samarth Kulkarni - Automation Engineer - LinkedIn The price of the stock has increased by 18.73% since. Now, I think the rest of the world and Asia is a different story. I think one of the advantages we have is, right from the get go we said we're going to do one global trial, you know, we're not going to separate our trial for U.S. and Europe. As a Research Associate at CloudThat and a recent graduate of KLEIT College in Karnataka with a Master's in MCA, I bring a strong foundation in computer science and a passion for Multi-Cloud to my work. They all have pimples and you dont. . See Photos. Samarth Speciality Clinic, Multi-Speciality Clinic in Wakad, Pune Samarth Kulkarni is a young and talented cricketer with immense potential. While at McKinsey, he co-led the biotech practice, where he focused on strategy and operations, and led initiatives in areas such as personalized medicine and immunotherapy. I think every patient so far has been free of symptoms as you compare that to lentiviral approaches, you know, the data look better, and when you combine that with the fact that CRISPR is a notionally safer approach relative to random integration of lentivirus, I think you'll have a huge advantage in the marketplace. What should we expect in terms of updates on the 110 program? Learn More about Samarth Kulkarni's net worth. I think ultimately, it's because that's how we can exploit the platform to the fullest extent, to bring transformative medicines for patients. She is a single mother of two children, a son, Samrath Bedi, and a daughter, Divya Chawla. Yes, I mean I think the initial data clearly derisked the B2M knockout approach which was the big question going into your first data set. Doctors for Colporrhaphy in Nashik-Pune Road, Nashik And so far we're continuing the trial, there is a lot of interest in the program, we're dose escalating as we go along; and we look forward to providing updates. Samarth Kulkarni Net Worth (2023) | wallmine IN Expertise: FEA, 1D & 2D simulation, Fluid flow. Samarth Kulkarni from Belagavi is now CEO of Crispr Therapeutics She prefers wearing cotton, khadi, linen and pure silk sarees. Get all the latest news and updates on Bollywood, Hollywood, South India film industry, cinemas in India, film stars, celebrities, movie reviews and much more at outlookindia.com. Prashant has been working with Samarth on the basic level of his game and giving valuable tips to improve his performance. And you mentioned Vertex, and I want to kind of drill into that a little more. Yes, and part of it depends on the data. This was revealed after a tweet from Dr. Kulkarni was shared widely among Belagavi residents with congratulatory messages and tags about his schooling in the city. Yes, I think -- you know, ViaCyte have an allogeneic version; I mean with embryonic stem cells, except it's not edited, right. Samarth Speciality Clinic in Wakad, Pune. Following the completion of the transaction, the chief executive officer now owns 290,279 shares of the company's stock, valued at . It is a well-designed beautiful Home in Maval. Dr. Kulkarni is also on the board of Black Diamond Therapeutics, Inc., Repare Therapeutics, Inc. and Centessa Pharmaceuticals Ltd. and Chief Executive Officer & Director at CRISPR Therapeutics AG and Director-Emerging Companies Section at Biotechnology Innovation Organization. Because then that would mean that, the allogeneic version that we're working on, which is edited, is also like those same efficacy in terms of production of insulin but we have the added advantage that can be stealth, and the patients don't need to be immunosuppressed, right. In the meantime, I think, CRISPR's capabilities are best harnessed thinking about what's sort of the next horizon; which is, how do we come up with gentle [ph] conditioning agents or expand the market? It has a built-up area of 550 Square feet. And, in fact, you're seeing some motional durability, it's -- we have to the trial this still early, but we can't really compare apples-to-apples, but there is a notion that patients can be in CR for a long time based on allogeneic therapies. Samarth Kulkarni. Learn More on Samarth Kulkarni's salary. Prof. Charpentier and Jennifer Doudna are the two scientists who have been selected for the coveted prize for their work on genetic scissors. The total sale was $2.8 million. To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser. Warning! Art & Entertainment News, Movie Reviews, Bollywood, Hollywood, OTT Please. Both trials are designed to enroll upto 45 patients, but we don't -- we don't even think that we may need 45 patients worth of data if the -- if our approval of the data continue to bear out and hold out. In addition, he makes $16,265,700 as Chief Executive Officer and Director at CRISPR . You will also learn to prioritise and do things that are important to you, and learn that everyone cannot do everything. Samarth Kulkarni, a Belgaumite recently assumed the role of CEO, Crispr Therapeutics a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases. And then, obviously, a few of the other companies looking at GSI inhibitors, gamma secretase inhibitors; is that an approach that you might think about looking at in the future or is that something that you're just going to wait and see how well B2M knockout works before making decisions on anything like that? Samarth Kulkarni has significant expertise in strategy and operations in biotech and a wide range of related cutting-edge therapeutic technologies. Yes. This week on the For Your Innovation Podcast, we're joined by Dr. Samarth Kulkarni, Chief Executive Officer of CRISPR Therapeutics. I think subsequent data releases have been as part of medical conferences, we did that with OO1 [ph]. We presented data and we said, "Oh, my God, you know, look at the response from physicians, from the patient community, the patients themselves". Yes. The father bought a gun two weeks before a Chester County family murder Later, she pursued graduation in Fine Arts at Stella Maris College, Chennai. At there, she had diligently handed over case to her husband Dr. Hemant Kulkarni, who is expert with his diagnosis and managed this case further. Divya works as the creative director of Forest Essentials. He had an exceptional performance in the recent South Zone matches held in Kerala in . View profile badges. Clitoropexy Doctors in Bytco Point, Nashik - View Cost, Book Tata Wiki, Age, Death, Wife, Children,, Saubhagyaa R Swain Wiki, Height, Age, Family,, Nandita Mahtani Wiki, Height, Age, Boyfriend, Husband,, Amer Kamra Wiki, Height, Weight, Age, Family,. Biden To Unleash "Choke Point" Operation On America? Sam joined CRISPR in early 2015 as Chief Business Officer. Great. And I think, for us with our allo-therapies, especially with the CD70 target, we think it's very attractive target given the expression and renal cell carcinoma in a highly immunologic cancer, I think it gives us that opportunity. This is a spiritual place with quotations written in the passage. CBS News Reports: "It's an entirely new type of weapon." Samarth Kulkarni Inventions, Patents and Patent Applications - Justia Akkalkot Swami Vatruksha Bhakta Niwas Kulkarni Dharamshala - YatraDham

Personal Licence Scotland Mock Test, Life Expectancy After Stroke At 40, Mark Herbert Eugene, Oregon, Sitka Alaska Real Estate Zillow, Articles S